GenomiCare Biotechnology
About:
GenomiCare Biotechnology is a Chinese precision cancer medicine service company
Website: http://www.genomicarebio.com/
Top Investors: Trustbridge Partners, General Oriental, GP Healthcare Capital, Apricot Capital, Carebridge Holdings
Description:
GenomiCare Biotechnology (Shanghai) Co., Ltd is a Chinese precision cancer medicine service company, providing personalized clinical precision medicine solutions and medical resources for Chinese cancer patients and doctors.
Total Funding Amount:
$30M
Headquarters Location:
Shanghai, Shanghai, China
Founded Date:
2015-01-01
Founders:
Qiang Xu
Number of Employees:
101-250
Last Funding Date:
2018-12-18
IPO Status:
Private
Industries:
© 2025 bioDAO.ai